Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 14Squamous Cell Carcinoma of Head and Neck 12Colorectal Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 10Carcinoma, Renal Cell 7Prostatic Neoplasms 6Head and Neck Neoplasms 6Diabetes Mellitus, Insulin-Dependent, 12 6Neoplasms 5Lung Neoplasms 5Biliary Tract Neoplasms 5Small Cell Lung Carcinoma 4Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Recurrence 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Advanced Solid Tumors 3Stomach Neoplasms 2Sarcoma 2Recurrent Squamous Cell Lung Carcinoma 2Liver Neoplasms 2Kidney Neoplasms 2Gallbladder Neoplasms 2Esophageal Squamous Cell Carcinoma 2

Interventions

pembrolizumab 124Cisplatin 27lenvatinib 24Carboplatin 24Paclitaxel 19Docetaxel 16Fluorouracil 13Capecitabine 11Pemetrexed 10Gemcitabine 10Saline Solution 8Oxaliplatin 8epacadostat 6Leucovorin 5Irinotecan 5Cetuximab 5olaparib 4Bevacizumab 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4trifluridine tipiracil drug combination 3regorafenib 3enzalutamide 3durvalumab 3Nivolumab 3Etoposide 3trametinib 2etoposide phosphate 2dabrafenib 2Tretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Parkinson Disease 4, Autosomal Dominant Lewy Body × tremelimumab × Clear all
NCT02735239 2024-03-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Ludwig Institute for Cancer Research

Phase 1/2 Completed
73 enrolled 18 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡